“`html

Why Your Thyroid Labs Look “Normal” but You’re Still Not Losing Weight on Semaglutide or Tirzepatide — What Standard Panels Miss and the Expanded Thyroid Screen a Real GLP-1 Program Should Run

If you’ve been on semaglutide or tirzepatide for weeks — or months — and the scale has barely moved, the first assumption most people make is that they’re doing something wrong. The second assumption is that the medication isn’t strong enough. Both are usually incorrect. For many women, thyroid and weight loss stall on GLP-1 medications are directly connected by a gap between what a standard blood panel reports and what is actually happening inside the body. The frustrating reality is that your doctor can run a thyroid test, hand back results labeled “normal,” and still miss the dysfunction that’s quietly blocking your progress.

Why a “Normal” TSH Doesn’t Tell the Whole Story

TSH — thyroid-stimulating hormone — is the most common marker ordered to check thyroid function. But TSH is not a measurement of what your thyroid is actually doing. It is a signal from the pituitary gland telling the thyroid to produce more hormone. A normal TSH means the pituitary is satisfied with the output it sees. It says nothing about whether that hormone is being converted into its active form, whether it’s reaching your cells, or whether your immune system is attacking the thyroid gland in the background.

Think of it this way: TSH tells you what the manager is requesting. It does not tell you whether the work is getting done.

For women dealing with a semaglutide not working thyroid situation — or finding that a tirzepatide plateau thyroid pattern persists despite dose adjustments — the real problem often lives downstream from TSH in markers most standard panels never test.

Standard Panel vs. Expanded Thyroid Screen: What’s Missing

A standard thyroid workup at most primary care offices includes TSH and, if you’re lucky, Total T4. That is it. An expanded thyroid screen — the kind used in a functional medicine approach to weight loss — examines several additional markers that paint a completely different picture:

• Free T4 — the storage form of thyroid hormone produced directly by the thyroid gland
• Free T3 — the active form your cells actually use; this is the marker that directly drives metabolic rate
• Reverse T3 (rT3) — a blocking molecule the body produces when under chronic stress; elevated rT3 essentially parks thyroid function in neutral regardless of what TSH shows
• Thyroid antibodies (TPO and TgAb) — elevated levels signal autoimmune thyroid disease (Hashimoto’s thyroiditis), which frequently causes measurable symptoms before TSH ever shifts out of the normal range

None of these markers appear on a routine thyroid check. Yet each one can explain precisely why a person following a GLP-1 program correctly is still not responding the way they should.

The Conversion Problem: Where T4 Becomes — or Doesn’t Become — T3

The thyroid primarily produces T4. But T4 is not metabolically active. It must be converted into Free T3 in the liver, gut, and peripheral tissues before it can affect metabolism, energy production, and fat breakdown. This conversion step commonly breaks down under conditions that are widespread in women pursuing weight loss:

• Chronic stress and elevated cortisol — one of the most reliable conversion blockers
• Low ferritin or iron deficiency — frequently found in women on GLP-1 medications, which reduce appetite and can lower dietary iron intake over time
• Selenium and zinc deficiency — both are direct cofactors in the conversion enzyme pathway
• Gut inflammation or disrupted microbiome — a significant portion of T4-to-T3 conversion occurs in the gut
• Sharp caloric restriction itself — the body reads a large caloric deficit as a stress signal and responds by slowing conversion as a protective measure

That last point matters more than most patients are told. Semaglutide and tirzepatide both significantly reduce appetite, which is part of how they work. But when caloric intake drops sharply, the body can respond by downregulating T4-to-T3 conversion — partially blunting the metabolic effect of the medication. This is one reason a physician-supervised GLP-1 weight loss program that monitors labs throughout treatment provides something a prescription alone cannot: the ability to catch this pattern early and respond clinically before a plateau becomes entrenched.

Hashimoto’s: The Silent Autoimmune Driver Behind Many GLP-1 Plateaus

Hashimoto’s thyroiditis is the most common cause of hypothyroidism in the United States, and it frequently goes undiagnosed for years because TSH can remain in the normal range while the immune system is actively damaging the thyroid gland. Women between 35 and 55 are disproportionately affected, and the symptoms overlap heavily with both GLP-1 plateau patterns and perimenopause: fatigue, hair thinning, unexplained weight gain, brain fog, cold intolerance, and stubborn fluid retention.

Testing thyroid peroxidase antibodies (TPO) and thyroglobulin antibodies (TgAb) is the only way to identify active autoimmune thyroid disease before TSH is disrupted. If Hashimoto’s is present and not addressed, it creates an ongoing inflammatory environment that can worsen insulin resistance, interfere with GLP-1 receptor sensitivity, and blunt the weight loss response even when medication is at a fully therapeutic dose.

What Functional Thyroid Testing for Weight Loss Should Actually Include

A GLP-1 plateau blood labs evaluation for a patient not responding to semaglutide or tirzepatide should include, at minimum:

• TSH (as a baseline reference point)
• Free T3 and Free T4 (to assess the conversion picture directly)
• Reverse T3 (to check for stress-related thyroid blocking)
• TPO antibodies and TgAb (autoimmune screening)
• Ferritin (the primary conversion cofactor that is routinely missed)
• Vitamin D and magnesium (thyroid co-factors that also directly affect insulin sensitivity and GLP-1 response)
• Cortisol (a stress hormone that drives rT3 elevation and promotes visceral fat storage regardless of caloric intake)

These markers do not exist in isolation. They interact with each other and with the broader hormonal environment — including estrogen, progesterone, and testosterone — which is one reason women in perimenopause often hit a wall faster than expected on GLP-1 medications. A thyroid conversion problem and a hormone imbalance are frequently running at the same time, compounding each other.

TSH Normal but Still Gaining Weight — What’s the Actual Next Step?

If you’ve been told your thyroid is “fine” based on a standard panel but you have classic hypothyroid symptoms and GLP-1 isn’t performing the way it should, the next step is an expanded panel — not a dose increase.

Increasing semaglutide or tirzepatide without identifying an underlying thyroid conversion issue is like pressing harder on the accelerator when the brakes are partially engaged. The medication can only accomplish so much when the metabolic environment is working against it. This is precisely where functional medicine and GLP-1 treatment belong together rather than in separate silos.

When GLP-1 stops working or weight comes back, the answer is often in the blood work. Made Ya Skinny takes a functional medicine approach — running the right labs, reading them correctly, and building a plan around what your body actually needs rather than defaulting to a higher dose and hoping for a different result.

What to Expect at Made Ya Skinny in Magnolia and Cypress, TX

At Made Ya Skinny, physician-supervised care means more than writing a prescription. The program is built around comprehensive lab evaluation that goes beyond the standard panel to identify the actual reason weight loss has stalled. Medical weight loss in Magnolia TX — and at the Cypress location — includes the kind of expanded thyroid and metabolic review that most clinics do not run. Telehealth visits are available throughout Texas and other qualifying states for patients who cannot travel to a clinic in person.

If thyroid function is part of your picture, it gets addressed as part of your weight loss plan — not as a separate referral that adds months to your timeline. Individual results vary, and no specific outcome can be guaranteed, but the goal is always the same: treat the whole person, not just the number on the scale.

Ready for Labs That Actually Answer the Question?

If you’ve been stuck on semaglutide or tirzepatide and standard labs keep coming back “normal,” it’s time to run the right tests with a physician who knows what to look for. Book your $17 visit at Made Ya Skinny and get a real picture of what’s happening in your thyroid, your hormones, and your metabolic pathway — and a plan built around your actual blood work, not a one-size-fits-all protocol.

“`